GI
STIM icon

GAMMA Investing’s Neuronetics STIM Stock Holding History

GAMMA Investing’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$885 Sell
681
-537
-44% -$781 ﹤0.01% 3905
2026
Q1 		$1.77K Buy
1,218
+537
+79% +$851 ﹤0.01% 3704
2025
Q4 		$940 Buy
+681
New +$1.43K ﹤0.01% 3806

Other funds holding STIM

MAM
Madryn Asset Management New York $36.9M AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

GAMMA Investing's STIM Position: Q2 2026 in Review

GAMMA Investing reduced its Neuronetics (STIM) stake by 44% in Q2 2026, selling an estimated $781 and leaving 681 shares worth $885. The position accounts for ﹤0.01% of the portfolio, ranked #3905.

GAMMA Investing first reported a position in STIM in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.77K in Q1 2026. 87 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

  • GAMMA Investing held 681 shares of Neuronetics worth $885 as of Q2 2026.
  • GAMMA Investing sold 537 Neuronetics shares in Q2 2026, an estimated $781.
  • Neuronetics made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #3905 holding.
  • GAMMA Investing first reported a position in Neuronetics in Q4 2025 and has held it in 3 quarters since.
  • GAMMA Investing's Neuronetics position peaked at $1.77K in Q1 2026.
  • 87 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.